A Comparative Analysis of Financial Records Between Software and Biopharmaceutical Corporations [ ]

This study provides a comparative analysis of financial records for companies whose primary focus is on software production. A comparative analysis is then provided between software producing corporations and those in the biopharmaceutical industry to give the reader an understanding of both similarities and disparities between the two industries. The report uses common financial ratios such as Return on Investments (ROI), Current Ratio, and Earnings per Share (EPS). Both sectors share similarities that it takes high initial investment to develop a marketable produce. Biopharmaceutical companies have the added hurdle of passing government regulations before marketing their product. This has a potentially adverse impact on their profit margin, which may account for the generally lower net income of the sector.